*ST四环(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000518 *ST四环

已收盘 04-30 15:00:00

{"stockData":{"symbol":"000518","market":"SZ","secType":"STK","nameCN":"*ST四环","latestPrice":1.91,"timestamp":1745996613000,"preClose":2.01,"halted":0,"volume":1370800,"delay":0,"changeRate":-0.0498,"floatShares":1030000000,"shares":1030000000,"eps":-0.1195,"marketStatus":"已收盘","change":-0.1,"latestTime":"04-30 15:00:00","open":1.91,"high":1.91,"low":1.91,"amount":2618200,"amplitude":0,"askPrice":1.91,"askSize":737675,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.1195,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746495000000},"marketStatusCode":5,"adr":0,"adjPreClose":2.01,"symbolType":"stock","openAndCloseTimeList":[[1745976600000,1745983800000],[1745989200000,1745996400000]],"highLimit":2.11,"lowLimit":1.91,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1029556222,"isCdr":false,"pbRate":5.57,"roa":"--","roe":"--","epsLYR":-0.1068,"committee":0,"marketValue":1966000000,"turnoverRate":0.0013,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-05-06。","floatMarketCap":1966000000},"requestUrl":"/m/hq/s/000518","defaultTab":"news","newsList":[{"id":"2532018273","title":"*ST四环（000518）2025年一季报简析：净利润减436.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532018273?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:46","pubTimestamp":1746053168,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期*ST四环发布2025年一季报。根据财报显示，*ST四环净利润减436.35%。截至本报告期末，公司营业总收入4384.17万元，同比下降22.26%，归母净利润-1591.47万元，同比下降436.35%。本次财报公布的各项数据指标表现不尽如人意。融资分红：公司上市32年以来，累计融资总额1.00亿元，累计分红总额5114.21万元，分红融资比为0.51。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100005058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"gpt_icon":0},{"id":"2531978309","title":"图解四环生物一季报：第一季度单季净利润同比减436.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531978309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531978309?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:53","pubTimestamp":1745924011,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物2025年一季报显示，公司主营收入4384.17万元，同比下降22.26%；归母净利润-1591.47万元，同比下降436.35%；扣非净利润-1856.6万元，同比下降517.8%；负债率31.7%，投资收益0.0万元，财务费用41.31万元，毛利率64.38%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900036806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"gpt_icon":0},{"id":"2531200135","title":"四环生物(000518.SZ)发布一季度业绩，归母净亏损1591.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531200135","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531200135?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:23","pubTimestamp":1745922218,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环生物(000518.SZ)发布2025年一季度报告，第一季度，公司实现营业收入4384.17万元，同比下降22.26%。归属于上市公司股东净亏损1591.47万元。归属于上市公司股东的扣除非经常性损益净亏损1856.6万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287513.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0086","BK0168","BK0046","BK0145","BK0239","000518"],"gpt_icon":0},{"id":"2528767982","title":"四环生物最新公告：子公司晨薇生态园已移出失信被执行人名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2528767982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528767982?lang=zh_cn&edition=full","pubTime":"2025-04-17 16:57","pubTimestamp":1744880248,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，全资子公司晨薇生态园因部分待执行款项未能如期支付，被昭通市昭阳区人民法院列入失信被执行人名单。近日，晨薇生态园已支付相关款项，并已被移出失信被执行人名单。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041700025435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0145","BK0086","BK0239","BK0168","000518"],"gpt_icon":0},{"id":"2527545002","title":"四环生物收盘下跌2.73%，最新市净率4.72，总市值22.03亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527545002","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527545002?lang=zh_cn&edition=full","pubTime":"2025-04-16 16:10","pubTimestamp":1744791048,"startTime":"0","endTime":"0","summary":"4月16日，四环生物今日收盘2.14元，下跌2.73%，最新市净率4.72，总市值22.03亿元。资金流向方面，4月16日，四环生物主力资金净流出743.14万元，近5日总体呈流入状态，5日共流入548.55万元。江苏四环生物股份有限公司主要从事生物医药制品、生产和销售以及绿化园林工程业务。最新一期业绩显示，2024年三季报，公司实现营业收入1.56亿元，同比-13.31%；净利润-14617155.78元，同比66.26%，销售毛利率68.85%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/16161049581245.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0145","BK0046","BK0086","000518","BK0168"],"gpt_icon":0},{"id":"2514317156","title":"四环生物：股票在2024年年度报告披露后将可能被实施退市风险警示","url":"https://stock-news.laohu8.com/highlight/detail?id=2514317156","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514317156?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:47","pubTimestamp":1740732473,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0086","399001","BK0168","BK0239","BK0145","BK0046","000518"],"gpt_icon":0},{"id":"2510579349","title":"四环生物（000518）2月12日主力资金净卖出696.10万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510579349","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510579349?lang=zh_cn&edition=full","pubTime":"2025-02-12 15:30","pubTimestamp":1739345405,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年2月12日收盘，四环生物报收于2.55元，下跌1.16%，换手率1.85%，成交量19.09万手，成交额4867.56万元。2月12日的资金流向数据方面，主力资金净流出696.1万元，占总成交额14.3%，游资资金净流入291.29万元，占总成交额5.98%，散户资金净流入404.81万元，占总成交额8.32%。四环生物主营业务：从事生物医药制品、生产和销售以及绿化园林工程业务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021200019707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000518","BK0168","BK0239","BK0145","BK0046"],"gpt_icon":0},{"id":"2505747839","title":"四环生物(000518.SZ)：邱为碧成为公司实控人","url":"https://stock-news.laohu8.com/highlight/detail?id=2505747839","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505747839?lang=zh_cn&edition=full","pubTime":"2025-01-22 21:18","pubTimestamp":1737551893,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环生物(000518.SZ)公告，于2025年1月22日，碧水投资收到中国证券登记结算有限公司出具的《证券过户登记确认书》，相关股份过户登记手续已完成，碧水投资成为公司的控股股东，邱为碧成为公司的实际控制人。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1242168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000518","BK0239","BK0145","BK0086","BK0046","BK0168"],"gpt_icon":0},{"id":"2505717543","title":"四环生物：福建碧水农业投资通过司法拍卖获公司27.78%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2505717543","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505717543?lang=zh_cn&edition=full","pubTime":"2025-01-22 18:51","pubTimestamp":1737543115,"startTime":"0","endTime":"0","summary":"金融界1月22日消息，福建碧水农业投资有限公司通过参与司法拍卖方式取得陆克平实际持有的四环生物股东郁琴芬、王洪明、陈建国账户内合计28,599万股股份，占四环生物总股本的27.78%。本次权益变动所涉标的股票网络竞拍成交价款为387,573,648元，资金来源于控股股东、实际控制人及控股股东之股东的借款。信息披露义务人基于对医药健康产业及上市公司价值和发展前景的信心，拟通过本次权益变动取得控制权。未来12个月内暂无改变上市公司主营业务等具体计划，后续若有相关调整将严格履行程序并及时披露。\n\n\r\n            责任编辑：钟离","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/22185147707762.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0145","BK0046","BK0086","000518","BK0168","BK0239"],"gpt_icon":0},{"id":"2505173097","title":"四环生物：碧水投资竞得28,599万股，公司控股股东及实控人变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2505173097","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505173097?lang=zh_cn&edition=full","pubTime":"2025-01-22 18:51","pubTimestamp":1737543113,"startTime":"0","endTime":"0","summary":"金融界1月22日消息，江阴法院对郁琴芬、王洪明、陈建国所持四环生物部分无限售流通股合计28,599万股进行公开司法拍卖，由碧水投资竞得，成交价格为387,573,648元。相关股份过户登记手续已完成，碧水投资成为控股股东，邱为碧成为实际控制人。此次变更不会导致公司主营业务重大变化，亦不会对财务状况产生重大不利影响，不影响公司独立性。目前公司生产经营正常。\n\n\r\n            责任编辑：钟离","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/22185147707763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0086","BK0046","BK0145","000518","BK0168"],"gpt_icon":0},{"id":"2505221269","title":"四环生物(000518.SZ)发预亏，预计2024年度净亏损0.68亿元至1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505221269","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505221269?lang=zh_cn&edition=full","pubTime":"2025-01-21 20:25","pubTimestamp":1737462336,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环生物(000518.SZ)发布2024年度业绩预告，预计全年归属于上市公司股东净亏损0.68亿元至1亿元。业绩亏损的主要原因为：公司因证券虚假陈述责任纠纷而增加了相关费用;受医药市场竞争的影响，北京四环生物制药有限公司主营业务收入下滑，业绩亏损;江苏晨薇生态园科技有限公司存货资产(苗木)受市场环境影响，价格下跌致资产减值损失;因2024年度夏季长期高温、台风等极端天气及日常养护的影响，苗木存货有一定数量的减损。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1241394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0086","BK0145","BK0239","000518","BK0046","BK0168"],"gpt_icon":0},{"id":"2505221401","title":"四环生物(000518.SZ)：邱为碧将成为公司实际控制人","url":"https://stock-news.laohu8.com/highlight/detail?id=2505221401","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505221401?lang=zh_cn&edition=full","pubTime":"2025-01-21 20:21","pubTimestamp":1737462116,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四环生物(000518.SZ)发布公告，2025年1月20日，碧水投资收到江阴法院出具的《执行裁定书》(2024)苏0281执7624号之二，郁琴芬、陈建国、王洪明持有的四环生物2.86亿股无限售流通股股票的所有权归买受人福建碧水农业投资有限公司所有，上述股票的所有权自本裁定送达买受人福建碧水农业投资有限公司时起转移。上述司法裁定所涉公司股份目前尚未完成过户。依据《执行裁定书》，若后续过户完成，将导致公司控制权发生变更。碧水投资将持有公司2.86亿股股份，占公司总股本的27.78%，成为公司新的控股股东，邱为碧将成为公司的实际控制人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1241388.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000518","BK0168","BK0086","BK0239","BK0046","BK0145"],"gpt_icon":0},{"id":"2505299382","title":"四环生物：预计2024年全年每股收益亏损:0.066元至0.0971元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505299382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505299382?lang=zh_cn&edition=full","pubTime":"2025-01-21 20:02","pubTimestamp":1737460970,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物发布业绩预告，预计2024年全年每股收益亏损:0.066元至0.0971元。四环生物2024年三季报显示，公司主营收入1.56亿元，同比下降13.31%；归母净利润-1461.72万元，同比上升66.26%；扣非净利润-1629.74万元，同比上升62.52%；其中2024年第三季度，公司单季度主营收入5018.6万元，同比下降14.25%；单季度归母净利润-355.91万元，同比上升35.78%；单季度扣非净利润-649.01万元，同比上升73.04%；负债率23.45%，投资收益0.0万元，财务费用158.67万元，毛利率68.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012100035489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0168","BK0086","BK0145","000518"],"gpt_icon":0},{"id":"2505838229","title":"四环生物(000518.SZ)：预计2024年亏损6800万元至1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505838229","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505838229?lang=zh_cn&edition=full","pubTime":"2025-01-21 19:48","pubTimestamp":1737460108,"startTime":"0","endTime":"0","summary":"格隆汇1月21日丨四环生物(000518.SZ)公布，预计2024年营业收入18,000万元-22,000万元，亏损6,800万元至10,000万元，扣非亏损6,300万元至9,500万元。本报告期公司业绩亏损的主要原因为：公司因证券虚假陈述责任纠纷而增加了相关费用；受医药市场竞争的影响，北京四环生物制药有限公司主营业务收入下滑，业绩亏损；江苏晨薇生态园科技有限公司存货资产（苗木）受市场环境影响，价格下跌致资产减值损失；因2024年度夏季长期高温、台风等极端天气及日常养护的影响，苗木存货有一定数量的减损。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/21194847668832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0086","BK0046","BK0145","000518","BK0168"],"gpt_icon":0},{"id":"2502000069","title":"四环生物（000518）1月9日主力资金净卖出747.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502000069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502000069?lang=zh_cn&edition=full","pubTime":"2025-01-09 15:29","pubTimestamp":1736407780,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2025年1月9日收盘，四环生物报收于2.61元，下跌1.88%，换手率3.55%，成交量36.55万手，成交额9542.96万元。1月9日的资金流向数据方面，主力资金净流出747.16万元，占总成交额7.83%，游资资金净流入534.22万元，占总成交额5.6%，散户资金净流入212.94万元，占总成交额2.23%。四环生物主营业务：从事生物医药制品、生产和销售以及绿化园林工程业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010900019399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0086","BK0168","000518","BK0239","BK0046"],"gpt_icon":0},{"id":"2501227174","title":"异动快报：四环生物（000518）1月6日9点47分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2501227174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501227174?lang=zh_cn&edition=full","pubTime":"2025-01-06 09:50","pubTimestamp":1736128250,"startTime":"0","endTime":"0","summary":"证券之星1月6日盘中消息，9点47分四环生物触及涨停板。目前价格2.64，上涨10.0%。其所属行业生物制品目前上涨。领涨股为华兰疫苗。该股为干细胞，医药概念热股，当日干细胞概念上涨1.72%，医药概念上涨1.27%。1月3日的资金流向数据方面，主力资金净流出695.65万元，占总成交额9.14%，游资资金净流出75.0万元，占总成交额0.99%，散户资金净流入770.66万元，占总成交额10.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010600005550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0168","BK0145","000518","BK0086","BK0239"],"gpt_icon":0},{"id":"2501424087","title":"生物制品板块异动拉升，四环生物领涨10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501424087","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501424087?lang=zh_cn&edition=full","pubTime":"2025-01-06 09:48","pubTimestamp":1736128087,"startTime":"0","endTime":"0","summary":"1月6日，生物制品板块盘中上涨1.55%，四环生物领涨10%，欧康医药、未名医药、华兰疫苗、英诺特涨超7%。板块实时资金流向显示，今日超大单净流出1803.65万元，今日小单净流入188.69万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/06094847140179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0145","BK0239","BK0086","BK0046","000518","BK0168"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746437326459,"stockEarnings":[{"period":"1week","weight":-0.0948},{"period":"1month","weight":-0.282},{"period":"3month","weight":-0.1872},{"period":"6month","weight":-0.271},{"period":"1year","weight":-0.1659},{"period":"ytd","weight":-0.2451}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":-0.017},{"period":"3month","weight":0.0087},{"period":"6month","weight":0.0021},{"period":"1year","weight":0.0561},{"period":"ytd","weight":-0.0217}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏四环生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"102819人(较上一季度增加3.44%)","perCapita":"10013股","listingDate":"1993-09-08","address":"江苏省无锡市江阴市滨江开发区定山路十号","registeredCapital":"102955万元","survey":"　　江苏四环生物股份有限公司主要从事生物医药制品、生产和销售以及绿化园林工程业务。主要产品有重组人白细胞介素-2、重组人表皮生长因子、重组人粒细胞集落刺激因子、重组人红细胞生成素、肝炎诊断试剂、体外诊断试剂、注射剂、园林绿化。生物制药方面，北京四环系国内最早从事生物医药研发、生产和销售的企业之一，为国家高新技术企业，技术水平先进，产品质量较高，在市场中享有一定知名度，主要产品EPO注射液、注射用白介素-2的市场认可度高。","listedPrice":2.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST四环(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST四环(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST四环,000518,*ST四环股票,*ST四环股票老虎,*ST四环股票老虎国际,*ST四环行情,*ST四环股票行情,*ST四环股价,*ST四环股市,*ST四环股票价格,*ST四环股票交易,*ST四环股票购买,*ST四环股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST四环(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST四环(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}